Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 09, 2023

SELL
$62.32 - $89.47 $3.27 Million - $4.7 Million
-52,500 Reduced 77.43%
15,300 $1.31 Million
Q1 2022

May 11, 2022

BUY
$57.92 - $72.58 $434,400 - $544,350
7,500 Added 12.44%
67,800 $4.03 Million
Q2 2021

Aug 11, 2021

BUY
$63.47 - $69.35 $3.83 Million - $4.18 Million
60,300 New
60,300 $4.15 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $110B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Opus Investment Management Inc Portfolio

Follow Opus Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Opus Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Opus Investment Management Inc with notifications on news.